Search terms
Results 1 - 10 of 113 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 12

EuroIntervention One-year clinical outcomes following BRS implantation for diffuse coronary lesions: a substudy from the GHOST-EU registry The incidence of target lesion failure (composite endpoint ...

Date : 06/05/2016 Item size : 32127 bytes

EuroIntervention Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated everolimus-eluting stent METHODS AND RESULTS The EVOLVE trial ...

Date : 06/05/2016 Item size : 32576 bytes

EuroIntervention Five-year clinical outcomes in a real-world population of patients with long coronary lesions treated with the 38mm cobalt-chromium everolimus-eluting stent The majority of patients ...

Date : 06/05/2016 Item size : 32120 bytes

EuroIntervention Five-year clinical follow-up of the PYTON (prospective evaluation of the Tryton side-branch stent with an additional Xience-V everolimus-eluting stent in coronary bifurcation ...

Date : 06/05/2016 Item size : 32164 bytes

EuroIntervention Treatment of de novo coronary lesions with a novel second-generation paclitaxel-coated balloon catheter: five-month clinical results Benezet J., Cañadas D., Del Rio A., ...

Date : 06/05/2016 Item size : 31983 bytes

METHODS AND RESULTS A total of 804 patients who underwent both post-intervention IVUS examination and long EES (≥28 mm in length) implantation were included from two randomised trials (RESET,REal ...

Date : 06/05/2016 Item size : 31271 bytes

EuroIntervention Procedural safety and intermediate term efficacy of zotarolimus-eluting Resolute Integrity stents in the management of native very-long segment coronary artery lesions: a prospective ...

Date : 06/05/2016 Item size : 31936 bytes

EuroIntervention Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation DES: a substudy of the BIOSCIENCE ...

Date : 06/05/2016 Item size : 31456 bytes

May A., Carlyle A., Robaei D., Pitney M., Ooi S., Giles R., Jepson N. AIMS The key concern in using bioresorbable vascular scaffolds (BVS) in CTO is the duration of clinical and safety ...

Date : 06/05/2016 Item size : 31268 bytes

SYNERGY was found to be noninferior to the permanent polymer coated PROMUS Element Plus stent for the primary endpoint of 12-month target lesion failure (TLF: composite occurrence of ischaemia-driven ...

Date : 06/05/2016 Item size : 32860 bytes